News | November 10, 2023
Intermountain Health files complain against Dr. Reddy’s and others
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
The collaboration brings a seamless digital experience to more formulators worldwide
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
The companies plan to start a pivotal Phase 3 trial in the coming months
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian Industry (CII)
Investment is additive to KKR’s existing health care growth strategy
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Subscribe To Our Newsletter & Stay Updated
